Drug Information
| Generic Name | Anlotinib |
| Trade Name | Anlotinib |
| Company Name | Chia Tai Tianqing Pharmaceutical Co. Ltd |
| Drug Type | Small molecule |
| Drug Class | VEGFR |
| Dose | 12 mg per flat dose |
| Route | p.o. |
| Schedule of Administration | 12 mg, once daily, administered orally for 2 weeks on/1 week off over a 21-day treatment course, until disease progression or unacceptable toxic effects. If the efficacy in any given patient was assessed as stable disease, partial response, or complete response after six cycles, anlotinib was maintained until disease progression or death. |
| Generic Name | S-1 |
| Trade Name | S-1 |
| Company Name | Lunan Pharmaceutical Group |
| Drug Type | Biological |
| Drug Class | Antimetabolite |
| Dose | 70 mg/m2 |
| Route | p.o. |
| Schedule of Administration | 70 mg/m2, twice a day, oral for 2 weeks on/1 week off, 21 days as a course of treatment, until disease progression or unacceptable toxic effects, for a maximum of six cycles. |
| Generic Name | Anlotinib |
| Trade Name | Anlotinib |
| Company Name | Chia Tai Tianqing Pharmaceutical Co. Ltd |
| Drug Type | Small molecule |
| Drug Class | VEGFR |
| Dose | 12 mg per flat dose |
| Route | p.o. |
| Schedule of Administration | 12 mg, once daily, administered orally for 2 weeks on/1 week off over a 21-day treatment course, until disease progression or unacceptable toxic effects. If the efficacy in any given patient was assessed as stable disease, partial response, or complete response after six cycles, anlotinib was maintained until disease progression or death. |
| Generic Name | S-1 |
| Trade Name | S-1 |
| Company Name | Lunan Pharmaceutical Group |
| Drug Type | Biological |
| Drug Class | Antimetabolite |
| Dose | 70 mg/m2 |
| Route | p.o. |
| Schedule of Administration | 70 mg/m2, twice a day, oral for 2 weeks on/1 week off, 21 days as a course of treatment, until disease progression or unacceptable toxic effects, for a maximum of six cycles. |
Drug Information
| Generic Name | Anlotinib |
| Trade Name | Anlotinib |
| Company Name | Chia Tai Tianqing Pharmaceutical Co. Ltd |
| Drug Type | Small molecule |
| Drug Class | VEGFR |
| Dose | 12 mg per flat dose |
| Route | p.o. |
| Schedule of Administration | 12 mg, once daily, administered orally for 2 weeks on/1 week off over a 21-day treatment course, until disease progression or unacceptable toxic effects. If the efficacy in any given patient was assessed as stable disease, partial response, or complete response after six cycles, anlotinib was maintained until disease progression or death. |
| Generic Name | S-1 |
| Trade Name | S-1 |
| Company Name | Lunan Pharmaceutical Group |
| Drug Type | Biological |
| Drug Class | Antimetabolite |
| Dose | 70 mg/m2 |
| Route | p.o. |
| Schedule of Administration | 70 mg/m2, twice a day, oral for 2 weeks on/1 week off, 21 days as a course of treatment, until disease progression or unacceptable toxic effects, for a maximum of six cycles. |
| Generic Name | Anlotinib |
| Trade Name | Anlotinib |
| Company Name | Chia Tai Tianqing Pharmaceutical Co. Ltd |
| Drug Type | Small molecule |
| Drug Class | VEGFR |
| Dose | 12 mg per flat dose |
| Route | p.o. |
| Schedule of Administration | 12 mg, once daily, administered orally for 2 weeks on/1 week off over a 21-day treatment course, until disease progression or unacceptable toxic effects. If the efficacy in any given patient was assessed as stable disease, partial response, or complete response after six cycles, anlotinib was maintained until disease progression or death. |
| Generic Name | S-1 |
| Trade Name | S-1 |
| Company Name | Lunan Pharmaceutical Group |
| Drug Type | Biological |
| Drug Class | Antimetabolite |
| Dose | 70 mg/m2 |
| Route | p.o. |
| Schedule of Administration | 70 mg/m2, twice a day, oral for 2 weeks on/1 week off, 21 days as a course of treatment, until disease progression or unacceptable toxic effects, for a maximum of six cycles. |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
